These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32690432)

  • 1. Genetically predicted iron status and life expectancy.
    Daghlas I; Gill D
    Clin Nutr; 2021 Apr; 40(4):2456-2459. PubMed ID: 32690432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically Predicted Serum Iron Status Is Associated with Altered Risk of Systemic Lupus Erythematosus among European Populations.
    Ye D; Zhu Z; Huang H; Sun X; Liu B; Xu X; He Z; Li S; Wen C; Mao Y
    J Nutr; 2021 Jun; 151(6):1473-1478. PubMed ID: 33693920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically predicted glucosamine and longevity: A Mendelian randomization study.
    Yoon SY; Narayan VP
    Clin Nutr ESPEN; 2022 Jun; 49():556-559. PubMed ID: 35623867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Iron Status on Risk of Coronary Artery Disease: A Mendelian Randomization Study-Brief Report.
    Gill D; Del Greco M F; Walker AP; Srai SKS; Laffan MA; Minelli C
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1788-1792. PubMed ID: 28684612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Genetically Determined Iron Status on Risk of Venous Thromboembolism and Carotid Atherosclerotic Disease: A Mendelian Randomization Study.
    Gill D; Brewer CF; Monori G; Trégouët DA; Franceschini N; Giambartolomei C; ; Tzoulaki I; Dehghan A
    J Am Heart Assoc; 2019 Aug; 8(15):e012994. PubMed ID: 31310728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of genetically determined iron status across the phenome: A mendelian randomization study.
    Gill D; Benyamin B; Moore LSP; Monori G; Zhou A; Koskeridis F; Evangelou E; Laffan M; Walker AP; Tsilidis KK; Dehghan A; Elliott P; Hyppönen E; Tzoulaki I
    PLoS Med; 2019 Jun; 16(6):e1002833. PubMed ID: 31220083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically predicted biomarkers of iron homeostasis and risk of non-ischemic cardiomyopathy: A mendelian randomization study.
    Huang H; Wang X; Yu Y; Cheng S; Long T; Niu H; Hua W
    Nutr Metab Cardiovasc Dis; 2024 Aug; 34(8):1950-1958. PubMed ID: 38740536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causal associations of iron status with gout and rheumatoid arthritis, but not with inflammatory bowel disease.
    Yuan S; Larsson S
    Clin Nutr; 2020 Oct; 39(10):3119-3124. PubMed ID: 32044136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mendelian Randomization Analysis of Systemic Iron Status and Risk of Different Types of Kidney Disease.
    Zhou J; Shi W; Wu D; Wang S; Wang X; Min J; Wang F
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron status and non-alcoholic fatty liver disease: A Mendelian randomization study.
    Sun K; Zhao JV; Nelson EAS; Wong VWS; Lam HSHS; Hui LL
    Nutrition; 2024 Feb; 118():112295. PubMed ID: 38103266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron Status and Cancer Risk in UK Biobank: A Two-Sample Mendelian Randomization Study.
    Yuan S; Carter P; Vithayathil M; Kar S; Giovannucci E; Mason AM; Burgess S; Larsson SC
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32092884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appraising the Associations Between Systemic Iron Status and Epigenetic Clocks: A Genetic Correlation and Bidirectional Mendelian Randomization Study.
    Guo Y; Li D; Hu Y
    Am J Clin Nutr; 2023 Jul; 118(1):41-49. PubMed ID: 37146762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron Status and Risk of Stroke.
    Gill D; Monori G; Tzoulaki I; Dehghan A
    Stroke; 2018 Dec; 49(12):2815-2821. PubMed ID: 30571402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein cholesterol and lifespan: A Mendelian randomization study.
    Daghlas I; Gill D
    Br J Clin Pharmacol; 2021 Oct; 87(10):3916-3924. PubMed ID: 33704808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically predicted iron status was associated with the risk of prostate cancer.
    Ying J; Wang B; Han S; Song J; Liu K; Chen W; Sun X; Mao Y; Ye D
    Front Oncol; 2022; 12():959892. PubMed ID: 36561528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron status and the risk of sepsis and severe COVID-19: a two-sample Mendelian randomization study.
    Mohus RM; Flatby H; Liyanarachi KV; DeWan AT; Solligård E; Damås JK; Åsvold BO; Gustad LT; Rogne T
    Sci Rep; 2022 Sep; 12(1):16157. PubMed ID: 36171422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between serum iron status and risk of asthma: a 2-sample Mendelian randomization study in descendants of Europeans.
    Huang L; Li L; Luo X; Huang S; Hou Q; Ge X; Lv Y; Mo Z; Yang X
    Am J Clin Nutr; 2019 Oct; 110(4):959-968. PubMed ID: 31380560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Circulating Antioxidants and Longevity: Insight from Mendelian Randomization Study.
    Yu Z; Zhang F; Xu C; Wang Y
    Biomed Res Int; 2022; 2022():4012603. PubMed ID: 35132376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-Specific Genetically Predicted Iron Status in relation to 12 Vascular Diseases: A Mendelian Randomization Study in the UK Biobank.
    Yang F; Bao Q; Wang Z; Ma M; Shen J; Ye F; Xie X
    Biomed Res Int; 2020; 2020():6246041. PubMed ID: 33195696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum iron status and the risk of lung cancer: a two-sample Mendelian-randomization study.
    Feng X; Zhao T; Liu X; Liu Y; Gao Y
    J Thorac Dis; 2023 Nov; 15(11):6291-6300. PubMed ID: 38090312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.